X-Aptamer Selection and Validation.
暂无分享,去创建一个
Hongyu Wang | David E Volk | Ganesh L Lokesh | Curtis H Lam | Varatharasa Thiviyanathan | Nancy Ward | David G Gorenstein | D. Volk | D. Gorenstein | V. Thiviyanathan | Curtis H. Lam | N. Ward | Hongyu Wang | G. L. Lokesh
[1] D. Volk,et al. An ab initio study of phosphorothioate and phosphorodithioate interactions with sodium cation , 2002 .
[2] M. Ferrari,et al. Bone marrow endothelium-targeted therapeutics for metastatic breast cancer. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[3] Michael Blank,et al. Aptamer Selection Technology and Recent Advances , 2015, Molecular therapy. Nucleic acids.
[4] Toshimasa Ishida,et al. Synthesis of 2′-O,4′-C-methyleneuridine and -cytidine. Novel bicyclic nucleosides having a fixed C3, -endo sugar puckering , 1997 .
[5] J. Szostak,et al. In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.
[6] D. Gorenstein,et al. Delivery of double-stranded DNA thioaptamers into HIV-1 infected cells for antiviral activity. , 2006, Biochemical and biophysical research communications.
[7] A. Barrett,et al. Selection of Thioaptamers for Diagnostics and Therapeutics , 2006, Annals of the New York Academy of Sciences.
[8] J. Hope,et al. Characterization of 2′-Fluoro-RNA Aptamers That Bind Preferentially to Disease-associated Conformations of Prion Protein and Inhibit Conversion* , 2003, Journal of Biological Chemistry.
[9] H. Rui,et al. Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.
[10] Andrew D Ellington,et al. Construction and selection of bead-bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries designed for rapid PCR-based sequencing. , 2002, Nucleic acids research.
[11] D. Volk,et al. Solution structure and design of dithiophosphate backbone aptamers targeting transcription factor NF-κB , 2002 .
[12] D. Gorenstein,et al. Aptamers containing thymidine 3'-O-phosphorodithioates: synthesis and binding to nuclear factor-kappaB. , 1999, Bioorganic & medicinal chemistry letters.
[13] Jonathan Richards,et al. Electrochemical aptamer scaffold biosensors for detection of botulism and ricin toxins. , 2015, Chemical communications.
[14] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[15] Poul Nielsen,et al. LNA (Locked Nucleic Acids): Synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition , 1998 .
[16] V. Henrich,et al. Nano-SPRi Aptasensor for the Detection of Progesterone in Buffer , 2016, Scientific Reports.
[17] S. Tope,et al. Aptamers as therapeutics , 2013 .
[18] M. Ferrari,et al. Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44. , 2010, Biochemistry.
[19] Mauro Ferrari,et al. E‐Selectin‐Targeted Porous Silicon Particle for Nanoparticle Delivery to the Bone Marrow , 2011, Advanced materials.
[20] D. Gorenstein,et al. A chemical approach for site-specific identification of NMR signals from protein side-chain NH3+ groups forming intermolecular ion pairs in protein–nucleic acid complexes , 2015, Journal of biomolecular NMR.
[21] S. Watowich,et al. Combinatorial selection of a RNA thioaptamer that binds to Venezuelan equine encephalitis virus capsid protein , 2007, FEBS letters.
[22] Eun Jeong Cho,et al. Applications of aptamers as sensors. , 2009, Annual review of analytical chemistry.
[23] Xin Li,et al. Identification of Thioaptamer Ligand against E-Selectin: Potential Application for Inflamed Vasculature Targeting , 2010, PloS one.
[24] D. Volk,et al. X-aptamers: a bead-based selection method for random incorporation of druglike moieties onto next-generation aptamers for enhanced binding. , 2012, Biochemistry.
[25] Yoon-Sik Lee,et al. RNA aptamers: a review of recent trends and applications. , 2013, Advances in biochemical engineering/biotechnology.
[26] M. Ferrari,et al. Thioaptamer Conjugated Liposomes for Tumor Vasculature Targeting , 2010, Oncotarget.
[27] D. Volk,et al. Thioaptamers targeting dengue virus type-2 envelope protein domain III. , 2014, Biochemical and biophysical research communications.
[28] E. Timofeev,et al. The Toolbox for Modified Aptamers , 2016, Molecular Biotechnology.
[29] R A Bendele,et al. Derivation of RNA aptamer inhibitors of human complement C5. , 1999, Immunopharmacology.
[30] Y. Zu,et al. Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy , 2014, Molecular therapy. Nucleic acids.
[31] Bruce A Luxon,et al. Combinatorial selection of a single stranded DNA thioaptamer targeting TGF-beta1 protein. , 2008, Bioorganic & medicinal chemistry letters.
[32] Jeffrey T. Chang,et al. Aptaligner: Automated Software for Aligning Pseudorandom DNA X-Aptamers from Next-Generation Sequencing Data , 2014, Biochemistry.